Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association

American Heart Association Council on Genomic and Precision Medicine; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Lifestyle and Cardiometabolic Health

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

Genetic diseases that affect the cardiovascular system are relatively common and include cardiac channelopathies, cardiomyopathies, aortopathies, hypercholesterolemias, and structural diseases of the heart and great vessels. The rapidly expanding availability of clinical genetic testing leverages decades of research into the genetic origins of these diseases, helping inform diagnosis, clinical management, and prognosis. Although a number of guidelines and statements detail best practices for cardiovascular genetic testing, there is a paucity of pediatric-focused statements addressing the unique challenges in testing in this vulnerable population. In this scientific statement, we seek to coalesce the existing literature around the use of genetic testing for cardiovascular disease in infants, children, and adolescents.

Original languageEnglish
Pages (from-to)e000086
JournalCirculation. Genomic and precision medicine
Volume14
Issue number5
DOIs
StatePublished - 1 Oct 2021

Keywords

  • AHA Scientific Statements
  • cardiomyopathies
  • channelopathies
  • connective tissue diseases
  • counseling, genetic
  • predictive genetic testing

Fingerprint

Dive into the research topics of 'Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association'. Together they form a unique fingerprint.

Cite this